CN1179748C - 冻干形式的稳定的药用组合物 - Google Patents

冻干形式的稳定的药用组合物 Download PDF

Info

Publication number
CN1179748C
CN1179748C CNB008012164A CN00801216A CN1179748C CN 1179748 C CN1179748 C CN 1179748C CN B008012164 A CNB008012164 A CN B008012164A CN 00801216 A CN00801216 A CN 00801216A CN 1179748 C CN1179748 C CN 1179748C
Authority
CN
China
Prior art keywords
substituted
group
compound
pharmaceutical composition
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB008012164A
Other languages
English (en)
Chinese (zh)
Other versions
CN1315865A (zh
Inventor
泽居清治
笠井昭宏
大友和三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16210881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1179748(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CN1315865A publication Critical patent/CN1315865A/zh
Application granted granted Critical
Publication of CN1179748C publication Critical patent/CN1179748C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CNB008012164A 1999-07-01 2000-06-29 冻干形式的稳定的药用组合物 Expired - Lifetime CN1179748C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP187713/1999 1999-07-01
JP18771399 1999-07-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100880760A Division CN100352495C (zh) 1999-07-01 2000-06-29 冻干形式的稳定的药用组合物

Publications (2)

Publication Number Publication Date
CN1315865A CN1315865A (zh) 2001-10-03
CN1179748C true CN1179748C (zh) 2004-12-15

Family

ID=16210881

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB008012164A Expired - Lifetime CN1179748C (zh) 1999-07-01 2000-06-29 冻干形式的稳定的药用组合物
CNB2004100880760A Expired - Lifetime CN100352495C (zh) 1999-07-01 2000-06-29 冻干形式的稳定的药用组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNB2004100880760A Expired - Lifetime CN100352495C (zh) 1999-07-01 2000-06-29 冻干形式的稳定的药用组合物

Country Status (28)

Country Link
US (2) US6774104B1 (cg-RX-API-DMAC7.html)
EP (1) EP1107777B1 (cg-RX-API-DMAC7.html)
JP (2) JP3381722B2 (cg-RX-API-DMAC7.html)
KR (1) KR100454784B1 (cg-RX-API-DMAC7.html)
CN (2) CN1179748C (cg-RX-API-DMAC7.html)
AR (1) AR024634A1 (cg-RX-API-DMAC7.html)
AT (1) ATE280583T1 (cg-RX-API-DMAC7.html)
AU (1) AU752265B2 (cg-RX-API-DMAC7.html)
BR (2) BRPI0006823B8 (cg-RX-API-DMAC7.html)
CA (1) CA2341568C (cg-RX-API-DMAC7.html)
CZ (1) CZ295720B6 (cg-RX-API-DMAC7.html)
DE (1) DE60015279T2 (cg-RX-API-DMAC7.html)
ES (1) ES2225161T3 (cg-RX-API-DMAC7.html)
HK (1) HK1040057B (cg-RX-API-DMAC7.html)
HU (1) HU229089B1 (cg-RX-API-DMAC7.html)
ID (1) ID29468A (cg-RX-API-DMAC7.html)
IL (2) IL141455A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01000601A (cg-RX-API-DMAC7.html)
NO (1) NO330353B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ510290A (cg-RX-API-DMAC7.html)
OA (1) OA11601A (cg-RX-API-DMAC7.html)
PL (1) PL200141B1 (cg-RX-API-DMAC7.html)
PT (1) PT1107777E (cg-RX-API-DMAC7.html)
RU (1) RU2251411C2 (cg-RX-API-DMAC7.html)
TR (1) TR200100609T1 (cg-RX-API-DMAC7.html)
TW (1) TWI233805B (cg-RX-API-DMAC7.html)
WO (1) WO2001002002A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200101589B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980827B2 (en) 2011-01-31 2015-03-17 Shanghai Techwell Biopharmaceutical Co., Ltd. Medicinal composition containing echinocandin antifungal agent micafungin and preparation method and use thereof

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
KR101016595B1 (ko) * 2002-07-31 2011-02-22 센주 세이야꾸 가부시키가이샤 수성액제 및 광안정화된 수성액제
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
PT1565201T (pt) * 2002-11-18 2019-02-05 Vicuron Pharmaceuticals Llc Métodos de administração de dalbavancina para o tratamento de infeções bacterianas
CN100515422C (zh) * 2004-03-04 2009-07-22 卫材R&D管理有限公司 含有苄脒衍生物的组合物及苄脒衍生物的稳定化方法
WO2005111033A2 (en) * 2004-05-19 2005-11-24 Neurosearch A/S Novel azabicyclic aryl derivatives
WO2006053383A1 (en) * 2004-11-22 2006-05-26 Anadis Ltd Bioactive compositions
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
KR20080028942A (ko) * 2005-07-20 2008-04-02 교와 메덱스 가부시키가이샤 생체 시료 중의 펩티드의 안정화 방법
CN1962852B (zh) * 2006-11-27 2011-11-09 西北农林科技大学 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
BR112014029108B1 (pt) * 2012-05-22 2022-02-08 Paion Uk Limited Composições que compreendem benzodiazepinas de curta ação, uso de uma mistura de pelo menos um dissacarídeo e pelo menos uma dextrana e método de preparação de uma composição farmacêutica
ES3026983T3 (en) 2013-03-15 2025-06-12 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
CN103330932B (zh) * 2013-04-26 2015-12-23 江苏豪森药业股份有限公司 一种米卡芬净或其盐的药物组合物
CN103330933B (zh) * 2013-04-26 2015-08-05 江苏豪森药业股份有限公司 含有米卡芬净或其盐的药物组合物
DK3003298T3 (da) * 2013-06-05 2024-06-17 Univ British Columbia Antifibrogene forbindelser, fremgangsmåder og anvendelser deraf
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101611349B1 (ko) 2014-04-14 2016-04-12 신우철 안정성이 개선된 밀크씨슬 엑스의 제형
US20170190742A1 (en) * 2014-05-29 2017-07-06 Shanghai Techwell Biopharmaceutical Co., Ltd. Composition of cyclic peptide compound, preparation method for same, and uses thereof
WO2016088863A1 (ja) * 2014-12-05 2016-06-09 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 ジアザビシクロオクタン誘導体の結晶及び安定な凍結乾燥製剤の製造法
WO2016107890A1 (en) 2014-12-31 2016-07-07 Galenicum Health S.L. Stable pharmaceutical compositions comprising micafungin
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
WO2018112330A1 (en) 2016-12-16 2018-06-21 Baxter International Inc. Micafungin compositions
WO2019005829A1 (en) * 2017-06-26 2019-01-03 Wayne State University METHODS AND COMPOSITIONS RELATING TO CANCER DEPENDENT ON HORMONE RECEPTORS
RU2666148C1 (ru) * 2017-10-05 2018-09-06 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH03240727A (ja) 1990-02-15 1991-10-28 Toyo Jozo Co Ltd ニューモシスチス・カリニ肺炎治療剤
IE990233A1 (en) * 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
JP3193735B2 (ja) 1991-07-24 2001-07-30 株式会社リコー カラー画像形成装置の搬送装置
RU2095081C1 (ru) * 1991-12-13 1997-11-10 Акционерное общество "Биофа" Фармацевтическая композиция антивирусного действия
JPH0651641A (ja) 1992-07-30 1994-02-25 Olympus Optical Co Ltd 湿式現像装置
JPH06172204A (ja) * 1992-12-09 1994-06-21 Asahi Chem Ind Co Ltd アクレアシン類含有リポソーム製剤およびその製造法
JP3240727B2 (ja) 1993-02-25 2001-12-25 ソニー株式会社 偏平型陰極線管の画像歪補正装置
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
DE122008000025I2 (de) 1994-10-07 2011-02-17 Astellas Pharma Inc Zyklische hexapeptide mit antibiotischer aktivität
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
EP1854877B1 (en) * 1996-03-08 2012-02-08 Astellas Pharma Inc. Process for the deacylation of cyclic lipopeptides
PE63998A1 (es) * 1996-04-19 1998-10-30 Merck & Co Inc Composiciones anti-fungosas
JPH09301997A (ja) 1996-05-17 1997-11-25 Yamanouchi Pharmaceut Co Ltd 新規環状ペプチド系化合物
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
JPH10279498A (ja) * 1997-04-07 1998-10-20 Nippon Shinyaku Co Ltd 慢性関節リウマチ治療剤
JP3544847B2 (ja) * 1998-01-16 2004-07-21 三菱電機株式会社 光学的情報再生方法および装置
KR20010112302A (ko) * 1999-03-03 2001-12-20 피터 지. 스트링거 제약학적 경구용 ｅｃｂ 조제물 및 조성물의 제조 방법
HK1040062A1 (zh) * 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980827B2 (en) 2011-01-31 2015-03-17 Shanghai Techwell Biopharmaceutical Co., Ltd. Medicinal composition containing echinocandin antifungal agent micafungin and preparation method and use thereof

Also Published As

Publication number Publication date
HK1040057B (zh) 2005-08-05
JP2002363097A (ja) 2002-12-18
HK1080724A1 (zh) 2006-05-04
ES2225161T3 (es) 2005-03-16
CA2341568C (en) 2011-10-25
ZA200101589B (en) 2002-09-02
ATE280583T1 (de) 2004-11-15
EP1107777A1 (en) 2001-06-20
CN1315865A (zh) 2001-10-03
PL346297A1 (en) 2002-01-28
NZ510290A (en) 2003-07-25
NO20010893D0 (no) 2001-02-22
AR024634A1 (es) 2002-10-16
BR0006823A (pt) 2001-06-05
MXPA01000601A (es) 2002-04-08
AU5572200A (en) 2001-01-22
HK1040057A1 (en) 2002-05-24
WO2001002002A1 (en) 2001-01-11
IL141455A (en) 2006-12-31
KR100454784B1 (ko) 2004-11-05
EP1107777B1 (en) 2004-10-27
CN1636591A (zh) 2005-07-13
RU2251411C2 (ru) 2005-05-10
HU229089B1 (en) 2013-07-29
JP2003503462A (ja) 2003-01-28
OA11601A (en) 2004-07-30
CZ20011186A3 (cs) 2001-09-12
BRPI0006823B8 (pt) 2021-05-25
NO20010893L (no) 2001-04-24
BRPI0006823B1 (pt) 2020-01-07
PL200141B1 (pl) 2008-12-31
HUP0103740A2 (hu) 2002-02-28
CN100352495C (zh) 2007-12-05
CA2341568A1 (en) 2001-01-11
CZ295720B6 (cs) 2005-10-12
HUP0103740A3 (en) 2002-08-28
DE60015279D1 (de) 2004-12-02
US7112565B2 (en) 2006-09-26
DE60015279T2 (de) 2005-05-25
TR200100609T1 (tr) 2001-07-23
JP4691866B2 (ja) 2011-06-01
AU752265B2 (en) 2002-09-12
ID29468A (id) 2001-08-30
TWI233805B (en) 2005-06-11
KR20010072903A (ko) 2001-07-31
NO330353B1 (no) 2011-04-04
JP3381722B2 (ja) 2003-03-04
US6774104B1 (en) 2004-08-10
US20040157769A1 (en) 2004-08-12
IL141455A0 (en) 2002-03-10
PT1107777E (pt) 2005-01-31

Similar Documents

Publication Publication Date Title
CN1179748C (zh) 冻干形式的稳定的药用组合物
CN1130223C (zh) 包含生长激素,氨基酸和非离子去污剂的药物配方
CN1050514C (zh) 眼用或鼻用抗过敏组合物
CN1367703A (zh) Hgf冻干制剂
CN1180846C (zh) 含有双膦酸或其盐的,用于皮下给药的凝胶体状药物组合物
CN1173739C (zh) 含人生长激素的水性药物组合物
CN1010279B (zh) 含有斯波胍灵活性成分的注射用药物组合物的制备方法
CN1871014A (zh) 含有前列腺素的药物组合物
CN1646172A (zh) 包含喜树碱衍生物的液体制剂以及冻干该制剂制得的药物组合物
CN1792362A (zh) 阿比朵尔及其盐的静脉给药制剂及制备方法
JP2004506017A (ja) 抗真菌剤組合せ使用
EP3373953B1 (fr) Composition a action rapide d'insuline comprenant un citrate substitue
CN1146417C (zh) 以奎纽普汀和达尔福普汀为主要成分的稳定药物组合物及其制备
CN1183908C (zh) 一种尼莫地平的注射用药物组合物及其制备方法
CN1820751A (zh) 替罗非班粉针剂及其制备方法
CN1283245C (zh) 硝酸异山梨酯的冻干粉针及其制备方法
CN1082368C (zh) 人绒毛膜促性腺激素液体制剂
CN1812794A (zh) 溶液药用组合物
US20030220237A1 (en) Pharmaceutical composition
WO2002053584A1 (en) Stabilized pharmaceutical composition in lyophilized form
HK1080724B (en) Stabilized pharmaceutical composition in lyophilized form

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ASTELLAS PHARMA INC.

Free format text: FORMER NAME OR ADDRESS: FUJISAWA PHARMACEUTICAL CO., LTD.

CP03 Change of name, title or address

Address after: Tokyo, Japan

Patentee after: Yamanouchi Pharma Co., Ltd.

Address before: Osaka City, Osaka of Japan

Patentee before: Fujisawa Pharmaceutical Co., Ltd.

CX01 Expiry of patent term

Granted publication date: 20041215

CX01 Expiry of patent term